Kyphon announces special meeting date for Medtronic vote:
This article was originally published in Clinica
Kyphon has set October 16 2007 as the date for a special meeting during which the company's shareholders will vote on its proposed $3.9bn merger with Medtronic. The deal, first signed at the end of July (see Clinica No 1267, p 2), is expected to close in the first quarter of 2008.
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.